
    
      This is an open-label, prospective study to investigate lipid-lowering efficacy and
      sympathetic response of normotensive hypercholesterolemia patients after receiving
      simvastatin 40 mg once daily for 3 months.

      The total duration of the study will be approximately 13 weeks, comprising of a 1-week (or 4
      weeks?) screening period and a 12-week active treatment period. 20 hypercholesterolemia
      patients with normal blood pressure will be enrolled into treatment group.
    
  